TruemorsStudy Finds Niacin Is Better Than Zetia At Reducing Artery Clogs
A new study published in the New England Journal of Medicine finds that Niacin (produced by Abbott and sold as Niaspan) is more effective than the new blockbuster drug ezetimibe (produced by Merck and sold as Zetia) at reducing artery-clogging deposits caused by high...
Drug giants unite to develop cancer therapy
Merck and AstraZeneca, two giant drug houses have announced plans to collaborate on a cancer drug therapy. They are both working on drugs that block a cancer's pathway to growth but when one way is blocked, the cancer may take another pathway. This collaboration... 
created by Barbara McPherson | 28 wks ago | updated 28 wks ago
93 views | 36 recommendations | 2 comments
93 views | 36 recommendations | 2 comments
Medical Madoff: Data Faked in 21 Studies
"Over the past 12 years, anesthesiologist Scott Reuben revolutionized the way physicians provide pain relief to patients undergoing orthopedic surgery for everything from torn ligaments to worn-out hips. Now, the... 
created by nukegingrich | 40 wks ago | updated 40 wks ago
598 views | 50 recommendations | 5 comments
598 views | 50 recommendations | 5 comments
Merck and Schering-Plough in $41 Billion Merger
Pharmaceutical giant Merck, known for its Gardasil product, is acquiring Schering-Plough in a $41 billion dollar merger. The overall goal is to compete more closely with Pfizer, which is the largetst pharma... 
created by Jordan Yerman | 41 wks ago | updated 41 wks ago
460 views | 13 recommendations | 7 comments
460 views | 13 recommendations | 7 comments
Merck approves use of its HPV vaccine Gardasil in males
Human papillomavirus, or HPV, is an oncogenic virus implicated in causing nearly 100% of all cervical cancer cases, but it does not just target females. It also infects males, and can cause anal, penile, neck...
created by Yuliya Talmazan | 1 year ago | updated 1 year ago
1250 views | 10 recommendations | 4 comments
1250 views | 10 recommendations | 4 comments
Brazil to produce generic AIDS drug
" © AP 2008-09-18 03:43:04 - BRASILIA, Brazil (AP) - Brazil's health minister says Latin America's biggest country will produce an inexpensive generic version of an AIDS drug made by Merck & Co. Jose...
Weekly Radio Spin -- Merck's Having Chest Pains
Listen to this week's edition of the "Weekly Radio Spin," the Center for Media and Democracy's audio report on the stories behind the news. This week, we look at how Barbie celebrates Earth Day, why Freedom's...
created by Center for Media and Democracy | 1 year ago | updated 1 year ago
163 views | 0 recommendations | 0 comments
163 views | 0 recommendations | 0 comments
Weekly Radio Spin -- It Pays to Be Duby-ous
This week, we look at why leaders in China -- and the U.S. -- think more propaganda is better, what happens when journalists wear a PR hat too, and who's joining Blackwater's crowded payroll. In "Six Degrees of...
created by Center for Media and Democracy | 1 year ago | updated 1 year ago
192 views | 0 recommendations | 0 comments
192 views | 0 recommendations | 0 comments
The Politics and PR of Cervical Cancer
The Center for Media and Democracy has completed a four part series of articles, The Politics and PR of Cervical Cancer, about the first FDA approved human papillomavirus (HPV) vaccine GARDASIL,... 
created by Karen Hatter | 2 years ago | updated 2 years ago
4180 views | 25 recommendations | 7 comments
4180 views | 25 recommendations | 7 comments
Merck tells AIDS vaccine volunteers who got jab
"WASHINGTON (Reuters) - Thousands of people who volunteered to test an experimental AIDS vaccine that may have actually raised the risk of infection will be told if they got the actual shot, researchers said on Tuesday. Merck & Co. Inc. and academic researchers said they...
Breaking: Merck Agrees to Pay $4.85 Billion for Vioxx Claims
Merck Agrees to Pay $4.85 Billion for Vioxx ClaimsThree years after withdrawing its pain medication Vioxx from the market, Merck announced today that it will pay $4.85 billion to settle 27,000 lawsuits by people...
created by johnegger23 | 2 years ago | updated 2 years ago
372 views | 0 recommendations | 0 comments
372 views | 0 recommendations | 0 comments
Creating A Market For And Testing HPV Vaccines
A quote from the American Cancer Society web site states:
Seventy percent (70%) of human papilloma virus (HPV) infections are typically gone within one year and 90% are gone within 2 years.
When I read this fact...
created by Karen Hatter | 2 years ago | updated 2 years ago
1523 views | 20 recommendations | 4 comments
1523 views | 20 recommendations | 4 comments
Public Health? Profit? What Drives The HPV Vaccination Campaign?
In November 2006, Merck & Co. Inc. began its high pressure saturation 'One Less' campaign for its genetically engineered drug, GARDASIL, being hailed as a tool to prevent cervical cancer caused by two of...
created by Karen Hatter | 2 years ago | updated 2 years ago
3304 views | 25 recommendations | 8 comments
3304 views | 25 recommendations | 8 comments
Mylan completes acquisition of generics business of Merck KGaA
"Robert J. Coury, Mylan's Vice Chairman and Chief Executive Officer said, "The new Mylan now has all of the critical attributes we need to ensure future success and deliver powerful growth. We have enhanced scale and stability, a truly global reach, vertical and horizontal...
HIV Vaccine Fails - Another Clinical Trial on Horizon?
A new HIV vaccine, supported by WHO and UNAIDS, being pushed by Merck hit a roadblock this week. The STEP program, which has participants in North America, Australia, South America, and the Caribbean, has,... 
created by ScienceDave | 2 years ago | updated 2 years ago
342 views | 12 recommendations | 3 comments
342 views | 12 recommendations | 3 comments
